生物治疗对部参与炎症性类风湿性疾病的有效性
Kaouther Maatallah1,2,3, Maissa Abbes2, Lobna Kharrat1,2,3
1Rheumatology Department, Kassab Orthopedics Institute, Ksar Saïd, Tunis, Tunisia.
Current rheumatology reviews
|January 22, 2026
概括
生物治疗为炎症性类风湿性疾病中的部参与提供了有希望的缓解,改善功能和稳定损伤. 由于对这些疗法的数据有限,需要进一步研究.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 整形外科 整形外科 整形外科
背景情况:
- 部受损是慢性炎症性类风湿性疾病的常见和衰弱的表现.
- 严重的关节疾病显著影响患者的功能,生活质量,并可能导致残疾.
- 虽然关节整形术是有效的,但保守的策略和生物治疗越来越多地被使用.
研究的目的:
- 审查目前关于生物治疗关节参与炎症性类风湿性疾病的疗效的证据.
- 总结这些疗法对症状,功能和结构损伤的影响.
- 为了识别有关部参与这些条件的知识差距.
主要方法:
- 对PubMed数据库进行了叙事审查.
- 包括案例报告,案例系列和到2024年发表的原始文章.
- 专注于评估部症状的生物治疗方法的研究.
主要成果:
- 瘤亡因子-α (TNFα) 抑制剂有效缓解部症状,改善功能,并稳定放射性损伤.
- 托西利祖马布显示出在系统性青少年形性关节炎中阻止和减少关节损伤的潜力.
- 介素-17/介素-23 (IL-17/IL-23) 轴抑制剂可缓解脊椎关节炎的关节疼痛,但它们对结构损伤的影响尚不清楚.
结论:
- 生物疗法,特别是TNFα抑制剂,在炎症性类风湿性疾病中的部参与方面显示出显著的益处.
- 托西利祖马布和IL-17/IL-23抑制剂显示有希望,但需要进一步调查关节结构损伤.
- 目前关于部参与这些疾病的数据有限,强调需要进行更广泛的研究.
相关概念视频
01:23Rheumatic Heart Disease I: Introduction
464
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
464
02:59Biological Effects of Radiation
17.7K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.7K
01:20Rheumatic Heart Disease IV: Nursing Management
288
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
288
01:30Inflammatory Bowel Disease II: Crohn's Disease
987
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
987
01:21Rheumatic Heart Disease III: Medical Management
303
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
303
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
515
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
515